From: "Micah Larkin" <lwwaleiintvd@yahoo.com>
To: <paliourg@iit.demokritos.gr>
Subject: [3] Don't Be the Last one on this
Date: Sun, 16 May 2004 00:05:14 +0300
MIME-Version: 1.0
Content-Type: text/html;
	charset="iso-8859-7"
Content-Transfer-Encoding: quoted-printable
X-Priority: 3
X-MSMail-Priority: Normal
X-MimeOLE: Produced By Microsoft MimeOLE V6.00.2900.2527

<html>

<head>
</head>

<body>

<p><font face=3D"Tahoma" size=3D"2"><b>Stock Finder Newsletter wants to =
inform=20
aggressive investors of a company that we feel is extremely undervalued =
and=20
poised for growth.</b><br>
<br>
<b>12 to 20 Plus Inc (OTCBB:TTTP)<br>
Fiscal Year End: Dec 31<br>
52 Week High: $.25<br>
Shares Outstanding : 30 Million<br>
Shares in the Public Float: 4 Million<br>
<br>
TARGET PRICE IN NEXT 3-5 DAYS: $0.75 - 0.80<br>
TARGET PRICE IN NEXT 10 DAYS: $0.92 </b><br>
<br>
</font><font face=3D"Tahoma"><b>The Company</b></font><font =
face=3D"Tahoma" size=3D"2"><br>
<b>12 to 20 Plus, Inc. (OTCBB: TTTP) is a late stage development company =
that=20
produces and markets (through its Neurochemical Research Group division) =
highly=20
effective condition-specific supplements, often referred to as =
neutraceuticals.
<br>
The products, manufactured by FDA-approved labs, contain a sophisticated =

combination of extensively researched nutritional elements and do not =
contain=20
herbs. Retail sales in the explosive dietary supplement market are =
expected to=20
hit $40 billion by the year 2007, according to Frost &amp; Sullivan =
reports. <br>
Marketing research, product development, Beta testing and various =
mergers and=20
acquisitions in 2003, has now positioned 12 to 20 Plus (TTTP) to roll =
out its=20
full product line consisting of 7 products of which they have their own=20
proprietary formula, into the multi-billion dollar Over the Counter =
(OTC)=20
market. 12 To 20 Plus is ready to capitalize on its exceptional product =
line.<br>
Key Facts about 12 to 20 Plus Inc<br>
<br>
- They have introduced 9 products to the market that the company owns =
the=20
proprietary rights to, products that have been produced in FDA approved =
labs.<br>
<br>
- One of their products Anaplex (antidepressant) is currently being sold =
and=20
distributed in Longs Drug Stores, one of America's leading drug stores =
with over=20
400 stores<br>
<br>
- The company is negotiating deals with two major distributors in Europe =
for=20
their healthcare products.<br>
<br>
- They are currently in process of attempting to market one their newest =

products a revolutionary re-hydration product to the U.S Military and to =
allied=20
forces overseas.<br>
<br>
<br>
The Industry<br>
The neutraceutical sector has experienced some great growth over the =
past five=20
years, being capped off in 2002 when revenues for the global nutrition =
markets=20
hit $160 billion. United States took responsibility for about 1/3 of =
that, with=20
$56.5 billion, 18.5 coming from the nutrition markets, $19.8 from =
functional=20
foods, and $4.4 billion from personal care products. It's safe to say =
that=20
globally we are looking for new ways to live healthier and longer lives, =
and=20
that pharmaceutical remedies could quickly be a thing of the past. <br>
It's estimated that 95% of medical doctors` practices entail writing=20
pharmaceutical prescriptions and that 50% of these prescriptions are to =
treat=20
the side effects of medications being utilized to treat the specific =
ailment.
<br>
People are no longer neglecting the facts that what they are putting =
into their=20
bodies, may not be good for them, medicinal foods or &quot;nutritionally =
high powered=20
foods&quot; have been in the natural products industry for a long time =
and through=20
emerging scientific research the public interest has the reached the =
mainstream.
<br>
It seems as though everywhere you look these days the talk is on dieting =
whether=20
it be the low carbohydrate/high protein Atkins diet, The Zone diet, or =
any of=20
the other millions of options we have, the world is concerned with =
weight.=20
According to the American Obesity Association, of adults over the age of =
20 in=20
the United States 127 million are overweight, 60 million are obese, and =
9=20
million are severely obese. Obesity increases the risk of illness from =
30=20
serious medical conditions. This fact is forcing many of the snack food =
and soft=20
drink companies to come up with new healthier products that meet the =
taste=20
standards of today's consumers.<br>
Comparable companies in this Sector<br>
<br>
- USANA Health Sciences Inc (Nasdaq:USNA) current price $27.39<br>
- Nutraceutical International Corp (Nasdaq:NUTR) current price =
$25.97<br>
- Vital Living Inc (OTCBB:VTLV) current price $.68</b><br>
<br>
<br>
<br>
<br>
<br>
<br>
<br>
<br>
<b>Disclaimer:</b><br>
<br>
</font><font face=3D"Tahoma" size=3D"1">This contains forward-looking =
statements=20
within the meaning of The Private Securities Litigation Reform Act of =
1995.=20
These statements may be identified by such terms as expect&quot;, =
&quot;believe&quot;, &quot;may&quot;,=20
&quot;will&quot;, =
&quot;explode&quot;,&quot;move&quot;,&quot;undervalued&quot; and =
&quot;intend&quot; or similar terms. The=20
information in the above statement could not be 100% accurate and the =
newsletter=20
is not responsible for this. We are NOT a registered investment advisor =
or a=20
broker dealer. This is NOT an offer to buy or sell securities. No =
recommendation=20
that the securities of the companies profiled should be purchased, sold =
or held=20
by individuals or entities that learn of the profiled companies. This =
newsletter=20
was paid $3000 in cash by third--party to publish this report.Investing =
in=20
companies profiled is high-risk and use of this information is for =
reading=20
purposes only. If anyone decides to act as an investor, then it will be =
that=20
investor's sole risk. Investors are advised NOT to invest without the =
proper=20
advertisement from an attorney or a registered financial broker. Do not =
rely=20
solely on the information presented,do additional independent research =
to form=20
your own opinion and decision regarding investing in the profiled =
companies. Be=20
advised that the purchase of such high-risk securities may result in the =
loss of=20
your entire investment. Void where prohibited. The owners of this =
publication or=20
their partners may already own free trading shares in TTTP and may =
immediately=20
sell all or a the time this date stated and are subject to change =
without=20
notice.</font><font face=3D"Tahoma" size=3D"2"><br>
</font><br>
&nbsp;</p>

</body>

</html>
